Advocate Group LLC Amgen Inc Transaction History

Advocate Group LLC

$551 Million
Q3 2024

A detailed history of Advocate Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Advocate Group LLC holds 6,213 shares of AMGN stock, worth $1.64 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

6,213

Previous 6,255 0.67%

Holding current value

$1.64 Million

Previous $1.95 Million 2.41%

% of portfolio

0.36%

Previous 0.39%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$309.38 - $337.38 $12,993 - $14,169	-42 Reduced 0.67%	6,213 $2 Million
Q2 2024 Jul 10, 2024	SELL	$262.75 - $319.31 $70,417 - $85,575	-268 Reduced 4.11%	6,255 $1.95 Million
Q1 2024 Apr 25, 2024	SELL	$268.87 - $324.56 $64,528 - $77,894	-240 Reduced 3.55%	6,523 $1.85 Million
Q4 2023 Jan 19, 2024	SELL	$255.7 - $288.46 $203,792 - $229,902	-797 Reduced 10.54%	6,763 $1.95 Million
Q3 2023 Oct 17, 2023	SELL	$218.65 - $271.46 $177,762 - $220,696	-813 Reduced 9.71%	7,560 $2.03 Million
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $289,050 - $341,796	-1,349 Reduced 13.88%	8,373 $1.86 Million
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $400,777 - $488,480	-1,775 Reduced 15.44%	9,722 $2.35 Million
Q4 2022 Jan 18, 2023	SELL	$229.03 - $291.01 $187,575 - $238,337	-819 Reduced 6.65%	11,497 $0
Q3 2022 Oct 19, 2022	SELL	$224.46 - $253.15 $107,740 - $121,512	-480 Reduced 3.75%	12,316 $2.78 Million
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $2.95 Million - $3.29 Million	12,796 New	12,796 $3.11 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advocate Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advocate Group LLC with notifications on news.

Account

Advocate Group LLC Amgen Inc Transaction History